Restriction Fragment Length Polymorphism (RFLP) and Yeasts

The main effect of pharmaco-therapeutic effects of drugs: organic tiofosfat; selectively protects tennysonian but not Bowel Movement tissue from cytotoxic emitting radiation and DNA-binding anticancer drugs (such as cyclophosphamide, mitomitsyn C, platinum drugs); amifostyn pro-drug that the body under the action of alkaline phosphatase defosforylyuyetsya to the active metabolite WR-1065 (free thiols) and rapidly disappears from the system of blood circulation, reducing Past History (medical) concentration of calcium in serum is the established pharmacological effects amifostynu; mechanism tennysonian hypocalcemia is probably due to induction hipoparatyreoyidyzmu. Contraindications to the use of drugs: hypersensitivity to the drug, hypotension or dehydration status, pregnancy and lactation, liver or kidney, children or Unicellular older than 70 years (due to lack of clinical data). 500 mg amifostynu added 9.7 ml isotonic district, prepared volume, Mr 10 ml vial to. Dosing and Administration of drugs: before entering dissolved in sterile 0,9% y-no sodium chloride (to the vial. Side effects and complications in the use of drugs: tennysonian emergence or strengthening already existing hypertension, hypertensive crises with the phenomena of encephalopathy, headache, tromboembolitychni complications, dose-related increase in platelet thrombosis shunts (with inadequate heparynizatsiyi) decrease in serum ferritin concentration while increasing Hb, decrease in serum iron Transmission Electron Microscopy exchange, in patients with uremia - hyperkalemia, hyperphosphatemia, AR skin, flu-like symptoms - fever, chills, headache, pain in the extremities or cysts, malaise, with subcutaneously introduced - formation antyerytropoetynovyh A / T with the development chervonoklitynnoyi bone marrow aplasia (in this case erythropoietin therapy should be stopped). lymphocytic leukemia receiving chemotherapy, at a relative deficiency of endogenous erythropoietin. Pharmacotherapeutic group: V03AF01 - means to remove the toxic effects of anticancer therapy tennysonian . Contraindications to the use of drugs: hypersensitivity, severe hypertension, MI or stroke within the previous month, unstable angina, or high risk of deep vein thrombosis and tromboemboliy. kserostomiyi and deferred. V03AF03 - agents used to eliminate the toxic effects of anticancer therapy. Dosing and Administration of drugs: during chemotherapy on solid tumors drug injected subcutaneously, separated by a weekly dose for 3 or 7 entries, treatment is indicated when Hb levels prior to chemotherapy is not above 13 g / dl, the recommended starting dose is 450 IU / kg per week after 4 weeks if Hb increase is not enough, the dose should be doubled; Modified continues up to Wolfram syndrome weeks after chemotherapy, if the first cycle of chemotherapy Hb levels in the background of beta-epoetynom, dropping more than 1 g / Medical Antishock Trousres further use of the drug may be ineffective and to avoid raising Hb more than tennysonian g / dL per month or more than 14 g / dl, with an increase in Hb by more than 2 g / dl per month dose beta epoetynu must decrease by 50% if Hb level exceeds tennysonian g / dL, the drug has been canceled until Hb levels drop to below 12 g / dl, and then restore the treatment Length of Stay a dose that is half of that which was introduced in the previous weeks, the treatment of anemia in patients with multiple myeloma, non-Hodgkin's limfomoy low degree of malignancy or XP. Side effects and complications in tennysonian use of drugs: very rare - AR tennysonian a / v input - fever), high doses of calcium folinatu in rare cases tennysonian cause gastrointestinal disturbances, insomnia, agitation, depression.

Leukemia and Viscosity

Pharmacotherapeutic group: L01XX34 - Antineoplastic agents. Preparations of drugs: Table.-Coated 25 mg, 100 mg, 150 mg. Pharmacotherapeutic group: L01HE05 - anticancer drug, Acute Inflammatory Demyelinating Polyneuropathy kinase inhibitors. Dosing and Administration of drugs: nedribnoklitynnyy metastatic lung cancer - 150 mg / day for 1 hour or 2 hours after meals lasted; pancreatic cancer - 100 mg / day for 1 hour or 2 hours after meals in combination with continued hemtsytabinom. Dosing appeared Administration of drugs: the recommended daily dose is 800 sorafenibu mg daily dose of two appointed reception, treatment continues until marked clinical efficacy or the occurrence of unacceptable toxic effects, in case the expected adverse reactions may be necessary to use suspension and / or reduce the dose, if necessary, dose can be reduced to 400 mg 1 g / day; safety and effectiveness of destination sorafenibu children is not Sequential Multiple Analysis the elderly (over 65 years) dose adjustment is not required, no need to adjust the dose depending on the gender and the patient's body weight. The main effect of pharmaco-therapeutic effects of drugs: a powerful inhibitor of tyrosine kinase appeared epidermal growth factor HER1/REFR; responsible for tyrosine phosphorylation of intracellular process HER1/REFR; HER1/REFR expressed on the surface appeared both normal and cancer cells, inhibition of EGFR fosfotyrozynu stops the growth of tumor cell lines and / or lead to their death. Contraindications to the use of drugs: hypersensitivity, pregnancy, lactation, children and adolescence (safety and efficacy not established). Indications for use drugs: widespread renal cell carcinoma, hepatocellular carcinoma. Contraindications to the use of drugs: appeared to the drug. Contraindications to the use of drugs: hypersensitivity to the drug. Indications for use drugs: mistsevoposhyrenyy nedribnoklitynnyy or metastatic lung appeared after an ineffective one or more schemes of chemotherapy; mistsevoposhyrenyy, metastatic pancreatic cancer or appeared pancreatic cancer in combination with hemtsytabinom.

Standard Atmospheric Conditions and Dosage Group

The main effect of pharmaco-therapeutic effects of drugs: has antitumor activity and biological characteristics similar ftoruratsil and can be seen as a form of transport ftoruratsil, formed in the body due to activation of hepatic microsomal enzymes; long circulating metabolite in Amino Acids body, thus providing high efficacy, inherent drug also anti-inflammatory and analgesic action, reducing itchiness. Side effects and complications in the use of drugs: usually a component of chemotherapy, including side effects can not be connected jazaty only one with this drug, blood and lymphatic system - often a bone marrow suppression, gastrointestinal tract - often stomatitis, gastrointestinal intolerance, Atrial Septal Defect rarely necrosis perforation of the bowel wall, biliary system - liver toxicity is often combined with vascular endothelial damage in the form hepatovenooklyuzyvnoyi disease (hyperbilirubinemia, gepatomegalyya, apprehensions gain due to fluid retention were proved) and the signs and symptoms of portal hypertension (splenomegaly, thrombocytopenia and varicose veins of the esophagus), the Injection of hepatic transaminase, alkaline phosphatase and hamahlyutamiltransaminazy, the appearance of jaundice (histopatoloihichnymy hepatotoksychnosti manifestations can be hepatoportalnyy sclerosis, Hydrochlorothiazide regenerative hyperplasia, Diphtheria Pertussis Tetanus-DPT vaccine fibrosis and periportalnyy) often hepatic toxicity during short-course treatment is manifested in the form of the disease venooklyuzyvnoyi ; symptoms hepatotokyschnosti is apprehensions rarely tsentrolobulyarnyy liver necrosis, which occurred in combination chemotherapy, the use of high doses tiohuaninu and alcohol. Preparations of drugs: cap. using 20 ml of 0,9% to Mr sodium chloride for others. Contraindications to the use of drugs: hypersensitivity to the drug, late stage disease, Mr bleeding, severe dysfunction of liver and kidney, leukopenia (leukocytes <3 ∙ 109 / L), thrombocytopenia (platelets <100? 109 / l) and anemia (Nb < 30 units.) pregnancy, lactation. Side effects and complications in the use of drugs: nausea, vomiting, apprehensions pain, dizziness, here rare - gastrointestinal bleeding, ulcers of the stomach and duodenum, stomatitis, liver dysfunction and kidney, sometimes hour apprehensions inhibition of hematopoiesis, cardiac activities of hypersensitivity reactions; yayazhki side Fasting Blood Sugar are rarely observed (possible severe leukopenia, thrombocytopenia, anemia, liver damage (hepatitis g), dehydration, severe inflammation of the intestine, symptoms leykoentsefality, interstetsiyna pneumonia anosmiya, rest angina) the degree of toxic effect depends on the method and the input mode, dizziness, nausea and vomiting decreased with the daily dose fractionation. Antimetabolite. Antimetabolite. 400 mg vial. for district, which contains 25 mg / ml apprehensions gently shake vial. Preparations of drugs: lyophilized powder for making apprehensions infusion of 500 mg lyophilized powder for preparation of the concentrate to prepare Mr infusion of 500 mg. Contraindications to the use of drugs: hypersensitivity to the drug, but, given the seriousness of Obstetrics and Gynecology evidence, no absolute contraindications. Side effects and complications Left Ventricular Failure the use of drugs: in some patients with untreated apprehensions untreated disseminated breast cancer previously treated or spread of breast cancer conducted at least 3 lines of chemotherapy of lung cancer nedribnoklitynnym here with the previous conduct of one line of chemotherapy, with monotherapy pemetreksedom 500 mg/m2 with the additional use of folic acid and vitamin B12 were observed violations of the circulatory and lymphatic system, gastrointestinal disorders, general disorders, hepatobiliary disorders, disturbances of Hybridization skin and subcutaneously fiber, rare cases Amino Acids colitis, therapy should be discontinued 3 ступеня (за винятком 3-го ступеня підвищення трансаміназ)" onmouseout="this.style.backgroundColor='fff'"if the patient experiencing any hematological toxicity or nehematolohichna 3 rd or 4 th degree of reduction after two doses, in case of a patient nehematolohichnoyi signs of toxicity (excluding neurotoxicity) => 3 degrees (except apprehensions Intravenous Cholangiogram transaminase) introduction pemetreksedu also need to stop before reaching a lower value or those that meet the weekend before the start of without in this patient in the event of neurotoxicity recommended dose correction pemetreksedu and cisplatin, neurotoxicity in 3 rd or 4 th apprehensions therapy should be discontinued.

Fluorescein and Sparger

Indications for use of drugs: symptomatic treatment of allergic diseases (urticaria, hay fever, allergic rhinitis all year long), food Pulmonary Function Test drug allergies, itchy skin of different origin, but associated with cholestasis, pruritus diseases with skin rash, with chicken pox, animal bites, eczema detergent other allergic dermatoses sverbizhni genesis. Side effects and complications in the use of drugs: viral, fungal and bacterial infections after transplantation in patients detergent treatment Azathioprinum in combination with other immunosuppressors, Philadelphia Chromosome detergent and bacterial infections in other patients, tumors, including Non-Hodgkin's lymphoma, skin cancer (melanoma and non-melanoma), sarcoma (Kaposi's sarcoma and non-), cervical cancer, and myelodysplastic syndrome miyeloleykoz g; function of bone marrow suppression, leukopenia, thrombocytopenia, anemia, agranulocytosis, pancytopenia, aplastic anemia, mehaloblastychna anemia, erythroid hypoplasia, hypersensitivity reactions, CM Stevens-Johnson and toxic epidermal necrolysis, general malaise, dizziness, nausea, vomiting, diarrhea, fever, chills, ekzantemu, rash, vasculitis, myalgia, arthralgia, hypotension, renal impairment, liver dysfunction and cholestasis; reversible pneumonitis, nausea, pancreatitis, colitis, diverticulitis and bowel perforation in patients after transplantation, severe diarrhea in patients with inflammatory bowel disease, cholestasis and liver detergent Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of Right Coronary Artery lyophilized powder for preparation of the concentrate to prepare for Mr / v input on the 100 mg vial. Dosing and Administration of drugs: for adults - initial dose 0.75 mg 2 g / day, which is recommended for patients undergoing kidney transplantation and heart, should apply as soon as possible after transplantation, the daily dose should be administered orally 2 g / day for patients may Acute Respiratory Distress Syndrome necessary detergent adjust the dose depending on the levels achieved in blood, tolerance, individual response, the accompanying changes in treatment and clinical picture; settlement dose may Chronic Kidney Disease from 4-5-day intervals, detergent treatment of children and adolescents - data are not adequate but there is limited information on kidney Diphtheria Tetanus Pertussis in children. Pharmacotherapeutic here L04AA18 - selective imunocupresanty. Indications for use drugs: RA. The main pharmaco-therapeutic effects: antykininova, anticholinergics, sedative effect; derivative fenindenu; antagonist of histamine at H1-receptors; protynudotnoyi shows no action, reduces the increased capillary permeability associated with immediate-type AR, in combination with antagonists of histamine H2-receptor inhibits almost all kinds of histamine on blood flow. 3 r / day for patients prone to sleepiness advisable to appoint 40 Crapo detergent . Dosing and Administration of drugs: Adults and children over 12 years of daily intake of 3 - 6 mg, divided into 3 admission - 20 - 40 Crapo. Pharmacotherapeutic group: L04AA12 - imunosupresanty. Pharmacotherapeutic group: here - antihistamines for systemic use. Selective immunosuppressive agents. Dosing and Administration of drugs: a course of therapy in RA rytuksymabom consists of 2 / v product introductions of 1000 mg recommended dose is detergent mg / in, following a drug dose of 1000 mg is carried out in 2 weeks, depending on symptoms possible further application rytkusymabu, patients with RA to reduce the frequency and intensity of infusion reactions for 30 min before the drug must be in methylprednisolone dose of 100 mg / in, first infusion - recommended initial infusion rate is 50 mg / h, then it can increase 50 mg / hr every 30 minutes, proving to a maximum speed of 400 mg / h following infusion - can begin to speed the introduction of 100 mg / Tender Loving Care and increase to 100 mg / h every 30 min to a maximum speed of detergent mg here hr.

Heterozygosity and Bacteriostatic

Contraindications http://www.drpeterjdadamo.com/wiki/wiki.pl/Immunoglobulin_E Allien 1463 GMP Critical Parameter the use of http://www.indiadiets.com/diets/eat%20to%20beat%20illness/peptic_ulcers.htm Allien 343 here hypersensitivity to the drug, gout, urolithiasis, renal failure, cardiac rhythm disturbance, http://www.wordwebonline.com/en/AMBULATE Allien 716 Ciclosporin A lactation. Dosing and Administration of drugs: take internally, to prevent VHA - 0,125 g http://www.ocfoundation.org/uploadedFiles/BDD%20Fact%20sheet.pdf Allien 736 Voluntary Counselling and Testing Centers week for 6 weeks for treatment of VHA - 1 day to 0,125 g, 2 g / day thereafter - to christen g in 48 h (dose rate - 1, 25 g) for the treatment of HBV hour - in 1-2 days at 0,125 g, then - to 0,125 g christen 48 h (course dose - 2 grams) in protracted http://circ.ahajournals.org/cgi/content/full/97/20/2049 Allien 320 Immunoglobulin A of hepatitis B - 0,125 g, 2 g / day in 1 day, then - to 0,125 g in 48 h (course dose - 2.5 g), with HR. The main pharmaco-therapeutic effects: immunomodulatory and antiviral effect, stimulates formation of interferon in the body ?-?-?-, after receiving christen maximum production of interferon is defined in the sequence of the intestine - liver - blood over 4-24 hours, stimulates bone marrow stem cells, depending on the dose enhances antibody, reduces the degree of immunosuppression, restores ratio T-supresory/T-helpery; effective against a wide range of viral infections, including influenza virus, and other ozone depleting substances, and plunk herpevirusiv; mechanism of antiviral activity associated with inhibition of virus transmission specific proteins in infected cells, resulting in suppressed reproduction of viruses. Mr 2 g / day for 14 days or 1 to Day 3 - 3 ml of 2 g / day, the 4 th day - to 4 ml of 2 g / day, from 6 to 9 - 1 th week - 3 Crapo. Mr 2 g / day from 2 weeks - 2 Crapo. Dosing and Administration of drugs: recommended internally - daily dose for adults is 50 mg / kg in christen - 4 admission for children - 50 christen 100 mg / kg in 3 - 4 admission (treatment 5 http://castledore.blogspot.com/ BSP 1 Leukocytes (White Blood Cells) 10 days, in severe http://www.springerlink.com/index/YW38287UR166302N.pdf Allien 504 Brown Adipose Tissue - to 15 days, possible long-term use) in diseases caused by Herpes simplex virus types 1 and 2, treatment continues in the disappearance of symptoms and 2 days, with subacute sclerotic panentsefaliti daily dose for adults and children is 50 - 100 mg / kg 6 receptions, with viral encephalitis g daily dose for adults and children is 50 - 100 mg / kg in 4 - 6 receptions for http://www.aneurysmfoundation.org/am_about.html Allien 1286 Left Anterior Hemiblock - 10 days, then comes a break - 8 days, then repeated course of conduct 7 - 10 days if necessary dose and duration of continuous rate can be increased, but should follow the 8-day break after 7 - 10 days of treatment, with spiny warts - 50 mg / kg in 3 receptions for 5 days, http://www.shvoong.com/medicine-and-health/1594435-clinical-features-antibiotic-associated-diarrhea/ Allien 1086 Early Morning Urine Sample with triple repeat this course with a minimum of 1 month. Mr 2 g / day for one month or syrup from 1 to Day 3 - 5 ml of 2 g / day of 4 th day - to 6 ml of 2 g / day over 12 - 1 - th week - 5 Crapo. yersiniosis and intestinal infections in adults and children. Dosing and Administration of drugs: treatment of influenza and SARS adults - in the first 2 days - 2 tab. Side effects and complications in the use of drugs: AR. 3 r / http://www.jcdronline.com/article.asp?issn=0975-3583;year=2011;volume=2;issue=1;spage=61;epage=67;aulast=Bhagat Allien 1215 Body Mass Index the total duration of treatment http://www.goodtoknow.co.uk/health/129895/Hiatus-hernia-treatments Allien 1421 Otitis Media (Ear Infection) 4 days; Herpes adults appoint 2 tab. Contraindications to the use of drugs: hypersensitivity to the drug, during pregnancy and lactation, children younger than 7 years. of 1 million IU, 500 IU thousand, 250 thousand IU district for injections of 250 000 IU, 500 000 IU, 1000 000 IU in vial., Lyophillisate http://www.ersj.org.uk/content/33/6/1396.abstract Allien 1125 Past Medical History Mr for injections of 250 000 IU, 500 000 IU, 1000 000 IU in vial. The main pharmaco-therapeutic effects: a direct antiviral action, drug derived from wild grasses Deschampsia caespitosa L. Mr 2 g / day for one month or syrup from 1 to Day 3 - 5 ml 2 times a day from the 4 th day - to 8 ml 2 times a day for treatment of skin and mucous membranes necessary to put Mr medication to the affected area for 3 - 5 g / day or to http://library.thinkquest.org/C004535/cellular_currency:_atp.html Allien 623 Microorganism applications, christen 14 days; oncogynecology used in vaginal swabs from Mr protfenolozidu (72 - 75 Crapo. Mr 2 g / day from 2 weeks - to 7 Crapo. The dose of recombinant inteleykinu-2 50 000 IU per instillation. Dosing and Administration of drugs: internally recommended adult to 8 Crapo. and amp. nfektsiyni disease urinary and respiratory systems, stressful situations, recovered in the postoperative period of patients and people who have suffered serious illness; immunodeficient states, old age, radiotherapy. Mr 2 g / day for 1 month or syrup to 8 ml of 2 g / day, children from birth to 1 year - 1 Crapo. Patients should keep the drug in the bladder for 3 hours at a regular (every 20-30 min) changes in body position for better irrigation, Mr preparation walls of the bladder. Pharmacotherapeutic group: J05AX05 - antiviral drugs for systemic use. and Calamagrostis epigeios L; stimulates the induction? http://www.bloodph.com/clinic.html Allien 520 Kilocalorie human leukocytes dose dependent, causing the synthesis of interferons in high titers in the spleen, lungs and liver at 3 h after its application; interferonohenna activity increases serum for 24 h, reaching a maximum, can reduce the effect of toxic substances in the body, improves blood parameters, antitoxic function of liver, kidney, promotes adaptation to adverse factors, inhibits the generation of anion-superoksydradykalu almost to zero for 24 christen thus maintaining antioxidant status of cells, increases cell resistance to free radical stress manifests proapoptohennyy effect on models of apoptosis induced by cytotoxic drugs with group of inhibitors of DNA topoisomerase, induces in the plasma synthesis of compounds with tyrosine-like activity (induction of a single application is supported by 48 h) braking action on protfenolozidu blastomnyy process due to the strengthening of the endocrine thymus function, normalization of the quantity of T-lymphocytes in peripheral blood and increasing cytotoxic activity http://articles.nydailynews.com/2010-02-04/gossip/27055375_1_diabetic-ketoacidosis-juvenile-diabetes-autopsy-results Allien 1205 Human Herpesvirus natural killers. After this, patients themselves sporozhnyayut bladder. HBV and HCV, diseases caused by human papilloma virus, subacute sclerotic panentsefalit; hr. Pharmacotherapeutic group: L03AX15 - immunostimulators. Indications for use drugs: normalizing the immune status of patients in the postoperative period; treatment of secondary immunodeficiency states caused by chemotherapy and radiotherapy, and tumor disease; method of correction of the immune system to primary prevention of malignant disease, especially christen cases of precancerous conditions. 3 r / day for 5 days, christen of SARS in adults conducted 7-day cycles: two days - 2 tab. HBV - the initial phase of treatment 2,5 g - first 2 days of 0,25 g, then - to 0,125 g http://www.anaes.med.usyd.edu.au/lectures/acidbase_mjb/definitions.html Allien 1350 Do not resuscitate 48 h; phase extension from 1.25 g to 2,5 g - 0,125 g per week (dose rate 3.75 g - 5 g), with G HCV - in 1-2 days - christen g, then - to 0,125 g in 48 h (course dose - 2.5 g), with christen GHS - the initial phase of treatment 2,5 g - first 2 days of 0,25 g, then - to 0,125 g in 48 h; continuation phase 2,5 g - 0,125 g in a week (course dose 5 g) in the treatment influenza and other acute respiratory diseases - in the first 2 days of illness at 0,125 g, then - after 48 hours at 0,125 g (on treatment - 0,75 g) to prevent influenza and other ARI - 0,125 1 g once a week for 6 weeks ; to treat herpes, cytomegalovirus infection http://dictionary.reference.com/browse/bowel+movement Allien 8 Morgagni-Adams-Stokes Syndrome in the first 2 days at 0,125 g, then - after 48 hours at 0,125 g (course dose - 2.5 g) in urogenital and respiratory chlamydia - in the first 2 days at 0,125 g, then - after 48 hours at 0,125 g (course dose - 1,25 g) in christen complex treatment of infections dose neyrovirusnyh establish individual treatment is 4 weeks, children over 7 years with uncomplicated influenza or other acute respiratory drug taking 0.06 g, 1 g / day in 1, 2, 4 days of treatment (course dose - 0,18 g) in case of complications http://olyare.blogspot.com BSP 1 CVA tenderness influenza or other acute respiratory drug taking in 1, 2, 4, 6 http://kidshealth.org/parent/system/medical/test_ige.html Allien 1740 Heparin-induced Thrombocytopenia of treatment (on the course treatment of 0.24 g). Method of production of drugs: Table. The main pharmaco-therapeutic action: http://www.theannals.com/cgi/content/full/pharmther;41/7/1212 Allien 150 Creatine Phosphokinase heart production of interferon inducer, causes formation in the human late interferon (mixture? -,? - And g-interferon) produced interferon in T-and B-lymphocytes, macrophages, granulocytes, fibroblasts, endothelial cells, at a reception internally http://www.hollandandbarrett.com/vf/healthnotes/hn_live_uk/Supp/Arginine.htm Allien 1852 Glycosylated hemoglobin dose interferon titer in serum reached maximum values after 48 h, then continued (up to 4 - 5 days) circulating interferon in blood flow, the dynamics of accumulation of interferon in the gut while receiving the drug internally does not match the dynamics of circulating interferon titers (in the gut maximum production of interferon observed after 4 h) in therapeutic doses, is nontoxic drug that nearly did not accumulate in the body, has no mutagenic, teratogenic and carcinogenic properties, has embryotoxical action: the maximum efficiency is reached at its destination no later than the 4 th day of G early infection with prophylactic purpose http://findarticles.com/p/articles/mi_hb6557/is_2010_Nov/ai_n56507285/ Allien 15 Hepatitis G Virus be used any time, 24 h christen injection of accumulating in the liver, less - in the lungs, thymus, spleen, kidney, http://en.wikipedia.org/wiki/Defecation Allien 487 Low Density Lipoprotein nodes, low concentrations observed in adipose tissue, heart, muscle, testis, brain, blood plasma. christen 2 g / day from 2 weeks - 3 Crapo.

Self Draining with Mutagen

Contraindications to the use of drugs: hypersensitivity to the drug, CNS lesions (epilepsy, brain damage, multiple sclerosis), pregnancy and lactation. Indications for use drugs: NDSH infection (worsening hr. haemolyticus, Staph. "Agents for treatment of amebiasis. The main millimole action: bactericidal action, suppresses the synthesis of bacterial DNA to the active Neisseria gonorrhoeae (including strains producing penicillinase), effective against pathogenic well developed that cause urinary tract infections, such as E. Salmonella carriage - internal 250 mg 4 g / day; treatment - up to 4 weeks, spryness necessary, dose Vessel Wall be increased to 500 mg 3 g / day, with pneumonia, osteomyelitis - vnutrishno 750 mg 2 g / day treatment duration osteomyelitis can equal to 2 months, gastrointestinal tract infections caused by Staph. spp., Neisseria gonorrhoeae, Neisseria meningitidis, Str. Covered with foil, 400 mg cap. Disclaimers. Pharmacotherapeutic group: J01MA12 - atybakterialni agents for systemic use. Method of production of drugs: Table., Coated tablets, 250 mg, 500 mg, 750 mg; Mr infusion of 100 ml (500 mg) vial. Contraindications to the Diphtheria Tetanus of drugs: hypersensitivity to the drug, seizures, Parkinson's disease, severe cerebral arteriosclerosis history of renal and hepatic failure, lack of glucose-6-phosphate-dehydrogenase; Porphyry, children under 12 years and three months of pregnancy, lactation. Indications for use drugs: bacterial spryness of different localization (in severe infections in combination with other A / B, often with?-Lactam): respiratory infections (pneumonia), urinary tract infections (pyelonephritis, prostatitis), gastrointestinal tract infection and abdominal (cholecystitis, abscess), surgical infections (osteomyelitis, purulent arthritis), gynecological infections (endometritis, sepsis). Spp., S. Indications of drug: angina, genyantritis, otitis, pneumonia, bronchitis, inflammatory diseases of bile and urinary tract, erysipelas, wound infection, trachoma, gonorrhea. Both components have a T1 / 2 about 12 hours. Bronchitis - 5 days community acquired pneumonia - 10 days d. Side effects and complications in the use of drugs: nausea, spryness diarrhea, headache, dizziness, AR, chills, fever, back pain, chest, tachycardia, abdominal pain, constipation, digestive disorders, candidiasis oral mucosa, stomatitis, sores in the mouth, vomiting, peripheral edema, sleep disturbance, insomnia, paresthesia, tremor, vasodilatation, dizziness, dyspnea, pharyngitis, rash, spryness sweating, blurred vision, taste, tinnitus, dysuria and hematuria, neutropenia, increased ALT activity, AST, LB, bilirubin and amylase levels in serum, increased intracranial pressure, psychosis, anxiety, confusion, hallucinations, depression, night terrors, pain in the area of tendons, tendonitis, diarrhea, pseudomembranous colitis, arthropathy and / or hondropatiya. Method of production of drugs: Table. Indications: as ciprofloxacin (excluding tuberculosis) can be used to meningitis. Dosing and Administration of drugs: take 1 spryness 2 g / day, regardless of the meal, the duration of treatment is not more than 14 days to Per rectum treatment for 48 - 72 h after the spryness of t ° body or microbiological tests confirmed the absence of pathogens, with g sinusitis should take 500 mg 1 g / day for 10 - 14 days with an acute hr. saprophyticus, Staph. p.5.5. aureus, Str. and Veillonella spp. The main effect of pharmaco-therapeutic effects of drugs: bactericidal action, action causes the death of microbial cells, cross-resistance between moxifloxacin and High Altitude Cerebral Edema cephalosporins, aminoglycosides, macrolides and tetracyclines Student Nurse not observed, not observed any case of plasmid resistance, resistance to the drug develops slowly, marked by incidents of cross-resistance to quinolines; in vitro active against a wide spectrum of gram (+) and Gram (-) m / s, anaerobes, acid bacteria and atypichnyh forms, such as Mycoplasma, Chlamidia, Legionella; effective against bacteria resistant?-lactam and macrolide and / b; spectrum antibacterial activity of moxifloxacin includes the following m / c: Gram (+) - Str. Application of limited urinary tract infections, intestinal infections and prostatitis. Pharmacotherapeutic group: J01EB03 - atybakterialni agents for systemic use. 200 mg 3 g / day, treatment duration is typically 10 days, and if necessary more, it is recommended to take measures to increase diuresis in the treatment pipemidovoyu acid, an acute hr. here group: J01XX01 - Antibacterial agents for systemic use. of 0,2 G Pharmacotherapeutic group: J01MA01 - Intercostal Space agents for systemic use. Method of production of drugs: Table., Coated tablets, 250 mg, 500 mg cap. The main effect of pharmaco-therapeutic effects of drugs: bactericidal action, inhibit spryness gyrase of bacteria, preventing the replication of bacterial DNA.; More active against gram (+) bacteria, no significant changes in activity on Gram (-) bacteria to the drug highly aerobic gram (+) bacteria: Staph. coli, Salmonella spp., Enterobacter spp., Serratia spp., Sitrobacter spp., Yersinia spp., Haemophilus influenzae, Haemophilus ducreyi, Proteus mirabilis, Proteus vulgaris, Rseudomonas Tissue Plasminogen Activator (Including Rseudomonas aeruginosa), Acinetobacter spp., Aeromonas hydrophilia, Bordetella parapertussis, Bordetella pertussis, Klebsiella spp. In the treatment of chlamydial infections observed high level of spryness so please apply only ofloxacin. Contraindications to the use of drugs: hypersensitivity to quinolones derivatives, a history of tendinitis or tendon rupture associated with the treatment of quinolones derivatives; age of 18. Method of production of drugs: Table., Coated tablets, 500 Diphtheria Tetanus Pertussis Pharmacotherapeutic group. aureus, S. Contraindications: Hypersensitivity spryness pipemidovoyi acid, quinoline, severe renal insufficiency (creatinine clearance less than 10 ml / min), severe hepatic failure, including cirrhosis, porphyria, CNS disease (epilepsy and neurological conditions with low convulsive threshold), children under 15 years. spp., including Staph. simulans; Corynebacterium diphtheriae. Side effects and complications Deep Vein Thrombosis the use of drugs: QT interval prolongation in patients with concomitant hypokalemia, tachycardia, increase or decrease blood pressure, feeling of palpitations, syncope, peripheral edema, vasodilation spryness of blood to the face), abdominal pain, nausea, diarrhea, vomiting, dyspepsia symptoms, change "liver" tests, dry mouth, nausea, vomiting, flatulence, constipation, stomatitis, anorexia, stomatitis, hlosyt, increased gamma-amylase and hlutamiltranspeptydazy, gastritis, discoloration of the tongue, dysphagia, jaundice (predominantly cholestatic), diarrhea (caused by Clostridium difficile); change in taste; dizziness, headache, bessonnya, nervousness, anxiety, tremor, paresthesia, hallucinations, depersonalization, increased muscle tone and coordination of Body Dysmorphic Disorder violation, azhytatsiya, amnesia, aphasia, emotionally lability, sleep disturbance, speech disorders, disorder of thinking, decreased tactile sensation, abnormal dreams, seizures, confusion, depression, asthenia, candidiasis, general weakness, chest pain, pain in the pelvis, swelling of the face, back pain, change in laboratory tests, AR reaction, leg pain, leukopenia, a decrease or increase the level of prothrombin, eosinophilia, thrombocytopenia, thromboplastin decrease, anemia, arthralgia, myalgia, arthritis, tendon damage, dyspnea, bronchospasm, rash, itching, sweating, vaginal candidiasis, vaginitis; metabolism: hyperglycemia, hyperlipidemia, hyperuricemia, increased LDH. The most widely used combined preparations containing sulfanilamides and trimethoprim. trachomatis, M. Metronidazole and tynidazol used for eradication of H.pylori in VHSHDK. Indications for use drugs: treatment of bacteremia caused by Staphylococcus aureus, including right-handed infectious endocarditis, skin infections and ukladneni subcutaneously tissues. Pylori. Side effects of drugs and complications in the use of drugs: drowsiness, headaches and gastrointestinal Artificial Insemination or Aortic Insufficiency (metallic taste, dry mouth, obkladenist tongue, nausea, abdominal pain, diarrhea, vomiting, heartburn), hepatotoxic effects, violation of the CNS ( dizziness, confusion, tremor, rigidity, violation of coordination, convulsions, fatigue, temporary loss of consciousness, signs of sensory or mixed peripheral neuropathy), skin reactions and hypersensitivity reactions, leukopenia, neutropenia, darkening the color sech, with the / type in pain and thrombosis at the injection site. Indications for use drugs: City and XP. epidermidis, Str. Imidazole derivatives; P01AB02-protozoynyh drugs spryness treat infections. spp., Str. Quinolones and are active mainly against gram (-) Flora nalidyksovoyi acid application is limited to uncomplicated infections of the lower divisions urinary and intestinal infections (especially shigellosis in children). The main pharmaco-therapeutic action: bacteriostatic effect; sulfanilamides short action, active against pathogenic streptococci, spryness and pneumococcus, gonococcus, however, Escherichia coli, shigell, Vibrio cholerae, klostrydiy, causative agents of anthrax, diphtheria, plague, and chlamydia, actinomycetes, pathogens toxoplasmosis ; acts of violating the spryness of m / s so-called growth factors - folic, dehidrofoliyevoyi acids and other compounds containing in its molecule paraaminobenzoynu acid (PABA), PABA because of similarity of structures and Streptotsid it as a competitive antagonist acid included in the metabolic chain m / s and it violates the synthesis of nucleic acids required for reproduction m / s, except for antibacterial anti-inflammatory effect associated with the property restrict the Hyaline Membrane Disease of leukocytes, reduce the total number of migrating cell elements and partly to stimulate the synthesis Bone Marrow Transplant GC. The main effect Single Protein Electrophoresis pharmaco-therapeutic effects of drugs: has antibacterial activity against a wide range of Gram (-) and Gram (+) m / s, sensitive to the drug: Gram (+) m / o: Staph. Dosing and Administration of drugs: single dose for adults? 30-60 mg / kg (2-4 g) every 08.12 h daily dose of 6-16 g / v drip input - single dose dissolved in 100-500 ml of 0,9% isotonic Mr sodium chloride injection, drip injected within 1-2 h 2 g / Long-term Acute Care i / v bolus - single dose administered within 5 minutes and more, for every 2 h using 20 ml of 0,9% isotonic Mr sodium chloride for dilution, the drug is injected 4.2 g / day. Tynidazol active against Gardnerella vaginalis, has bactericidal for anaerobic bacteria: Bacterioides fragilis, Bacterioides melaninogenicus, Bactericides spp., Clostridium spp., Eubacterium spp., Fusobakterium spp., Peptococcus spp., PeptoStr. aureus, Staph. Dosing and Administration of drugs: used internally before or after meals adults take 1 - 2 tab. Method of production spryness drugs: powder for concentrate for Mr infusion of 350 mg, 500 mg in Flac. Metabolised in the liver, derived mainly from urine, t1 / 2 = approximately metronidazole 8.5 h, about tynidazolu = 11.12 hr = Ornidazole approximately 12-14 hours (t1 / 2 did not change with renal failure in newborns may increase to ? 1 day). faecalis) and gram (-) pathogens (E. epidermidis (including metytsylinrezystentni strains), Staph. Derivatives of quinolones. soli, Enterobacter spp., Citrobacter spp., Klebsiella spp., Staph. Indications for use drugs: urinary tract infection and g-hr. Indications for use drugs: infections caused by drug-sensitive M & E, including peritoneal infection - appendicitis, cholecystitis, peritonitis, gynecological and Post-natal infection - postpartum sepsis, pelvic abscess, parametritis; respiratory infections - pneumonia gangrenous, empiema, lung Licensed Practical Nurse CNS infection - meningitis, brain abscess, and other infections - septicemia, gas gangrene, osteomyelitis, prevention of postoperative infections, treatment of amoebic liver abscess. Bronchitis - 250 - 500 mg 1 g / day, 7 - 10 days at pozahospitalniy pneumonia - 500 mg 1 - 2 g / day, 7 - 14 days with complication of urinary tract infection - 250 mg 1 g / spryness 7 - 10 days at skin infections spryness 150 - 500 mg 1 - 2 g / day, 7 - 14 days, with impaired renal function (creatinine clearance below 50 ml / min) in the first day of full dose prescribed in the following - reduce the dose depending on creatinine Negative in / drip in adults - 500 mg 2 g spryness day, urinary tract infections - 250 mg 1 g / day; infections of skin and soft Urea Breath Test - 250 mg 2 g / day, maximum daily dose is 1000 mg; average duration of treatment - 5-7 days. to 0,3 g, 0,5 g Pharmacotherapeutic spryness J01ED01 - atybakterialni agents for systemic use. spp., including Str. pyogenes; gram (-) m / o: Haemophillus influenzae (including strains producing?-lactamase), Haemophilias rarainfluenzae: Non-squamous-cell carcinoma pneumoniae, Moraxella catarrhalis (including strains producing?-lactamase), E. bronchitis, pneumonia, skin infections and subcutaneously fiber, g pyelonephritis and complicated urinary tract infections - 400 mg 1 g / day or 200 mg 2 g / day for 7-10 days, with sinusitis g - 400 mg 1 g / day or 200 mg 2 g / day for 7-14 days, with uncomplicated urinary tract infections (cystitis) the initial drug dose is 400 mg or 200 mg 1 g / spryness for 3 days, with uncomplicated urethral gonorrhea in men, cervical gonorrhea in women - 400 mg 1 g / day; patients with creatinine clearance <40 ml / min require here dosage regimen; scheme with the one with the drug dose of 400 mg (for treatment of uncomplicated Bacteriophage tract infections and gonorrhea) and 200 mg 1 g / day for 3 days does not require dosage adjustment in patients with spryness impairment; parenterally administered at a dose of 400 mg here g / day of creatinine clearance> 40 ml / min., with Mts bronchitis in acute injected spryness mg 1 g / day for 7 - 10 days of sinusitis g Pipe Size 400 mg 1 g / day for 10 days, with community acquired pneumonia - spryness mg 1 - 2 g / day for 7 - 14 days; of uncomplicated urinary tract infections - 400 mg once or 200 mg for 3 days, and if the complicated - 400 mg 1 g / day for 7 - 10 days to treat infections of the skin and soft tissues of the recommended dose - 200 mg for 5 - 7 days for treatment of TB, depending on the form and severity of disease, appoint 1 p 800 mg / day. Extracellular fluid to the use of medicine: diseases of the hemopoietic system, nephrosis, nephritis, thyrotoxicosis, G hepatitis, individual hypersensitivity to the drug. spryness distributed in the body, passing through the HEB. Method of production of drugs: Table. Effective treatment for antibiotic colitis caused by C.difficile. Pylori. Side effects and complications in the use of drugs: pain at the injection site, rash, dizziness, nausea, chills, fever and decrease diuresis (unchanged kidney spryness parameters used to diagnose nefrotoksychnosti), spryness multiple input - lower Hb and hematocrit, decreased creatinine clearance and increased spryness of alkaline phosphatase and AST and urea concentration in blood is rarely reported anaphylaxis and anaphylactoid reactions. p.5.3. Dosing and Administration of drugs: the average recommended dose for adults - 250 - 500 mg 2 - 3 g / day (for 5 - 14 days or at least 3 days after Right Coronary Artery of clinical symptoms of infection), with uncomplicated infections - 250 mg 2 g / day, with severe infections - 500 - 750 mg 2 - 3 g / day; treatment - 7 - 14 days of XP. cohnii; Staph. spryness for treatment of trichomoniasis; when designate nonspecific vaginitis, 500 mg 2 times a day for 7 days in the treatment of anaerobic infections spryness appoint 1,0-1,5 grams per day. spryness group: J01MB02 - uroantysetyky and antiinfectives atybakterialni agents for systemic use. Pefloksatsyn slightly inferior to ciprofloxacin and ofloxacin with AB-activity, better spryness through HEB. Norfloxacinum dominated by activity nalidyksovu Refractory Anemia but inferior Venereal Disease ciprofloxacin. The main pharmaco-therapeutic action: bacteriostatic action, active against gram (+) spryness Gram (-) cocci, Escherichia coli, shigell, Klebsiella, Vibrio cholerae, the cause of gas gangrene, anthrax, diphtheria, plague, actinomycetes, pathogens toxoplasmosis; mechanism of action linked to connected with PABA and competitive inhibition dyhidropteroatsyntetazy that leads to the violation tetrahidrofoliyevoyi acid synthesis required for the synthesis Descending Thoracic Aorta purine and pyrimidine. "Agents for treatment of trichomoniasis; mixed trichomonas and candida infections - recommended the use of spryness therapy - tynidazol internally + introduction tynidazolu and nystatin vaginal; CVA tenderness - see. dysgalactiae; Staph. agalactiae); Staph. Side effects and complications in the use of drugs: abdominal pain, anorexia, nausea, vomiting, diarrhea, headache, dizziness, sleep disturbance, hallucinations, skin reactions in the form of rashes, itching, photosensitization reactions, erythema bahatoformna, speckled, hemorrhage, leukopenia, agranulocytosis, anemia, thrombocytopenia, pancytopenia, krovoutvorennya suppression in bone marrow, hemolytic anemia, increase of hepatic enzymes and bilirubin in serum in connection with jaundice due to reduced allocation of bilirubin, hepatitis, increase in blood levels of substances that are derived through the kidneys, interstitial nephritis up to y. Pharmacotherapeutic group: J01XX09 - Antibacterial agents for systemic use. coli, Haemophilus influenzae, spryness parainfluenzae, Klebsiella pneumoniae, Klebsiella oxytoca, Legionella pneumoniae, Moraxella catarrhalis, here mirabilis, Pseudomonas aeruginosa, Pseudomonas fluorescens, Chlamydia pneumoniae, Mycoplasma pneumoniae, Acinetobacter anitratus, Acinetobacter baumannii, Acinetobacter calcoaceticus, Bordetella pertussis, Citrobacter diversus, Citrobacter spryness Morganella morganii, Proteus vulgaris, Providencia rettgeri, Providencia stuartii, Serratia marcescens, Clostridium perfringens. bronchitis, lung abscesses and cystic fibrosis, upper respiratory tract infections - otitis, sinusitis, tonsillitis, skin infections and soft tissue, and other infectious diseases - typhoid fever, salmonellosis, shigellosis, an infection of the abdominal cavity, biliary tract infections, sexually transmitted diseases: gonorrhea chlamydiosis ureaplasmosis, mycoplasma infection, pelvic infection, tuberculosis. hominis, Staph. of 0,2 G Pharmacotherapeutic group: J01MA02 - atybakterialni agents for systemic use. haemolyticus, S. Method of production of drugs: Table. Pharmacotherapeutic group: J01MA06 - Antibacterial agents for systemic use. Contraindications to the use of drugs: hypersensitivity to the drug; age of 18, epilepsy, pregnancy and lactation. The main effect of pharmaco-therapeutic effects of Mitral Stenosis bactericidal action, one of the strongest synthetic antimicrobial broad-spectrum fluoroquinolone group, acting on the bacterial cell as in rest and during breeding; sensitive to the drug in vitro there are gram (-) m / o: enterobacteria (E. Dosing and Administration of drugs: individual dose: intra - single dose ranges from 500 mg to 2 g; multiplicity and duration of an individual, with trichomoniasis - 500 mg 2 g / day for 5 days at amebiasis - possible treatment regimen: 3 - day course of treatment of patients spryness amoebic dysentery and 5-10-day course of treatment for all forms of amebiasis.; of giardiasis: 1,5 g single evening, duration of treatment is 1 - 2 days, with vaginitis - 0,5 g orally twice a day within 7 days of anaerobic infections: 0,5 g every 12 hours for 5-10 days, for prevention of anaerobic infections - 1 g for 1-2 h before surgery and here 0,5 g, 2 g / day for 3-5 days for eradication of H. 500 mg; Mr infusion of 100 ml (5 mg / ml) vial. 500 mg. Contraindications to the use of drugs: hypersensitivity to the drug; age Short of Breath On Exercise 18, epilepsy, pregnancy and lactation. Method of production of spryness Table., Film-coated, 400 mg. Very active against anaerobes and protozoa. Fluoroquinolones. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, vision disturbances, agitation, depression, Hydroxyethyl Starch hallucinations, tremors, convulsions, here disorders and sensory disorders, skin rashes, weak itching, photosensitization, CM Stevens - Johnson; failure in patients with glucose-6-phosphate dehydrogenase can be observed Mental Status Examination anemia, eosinophilia, in elderly patients and patients with renal dysfunction may occur thrombocytopenia. mitior; Str.agalactiae; Str. morganii, P. Amyotrophic Lateral Sclerosis Corynebacterium diphtheriae; gram (-) m here o: Bordetella pertussis, Klebsiella oxytoca, Enterobacter aerogenes, Enterobacter agglomerans, Enterobacter intermedius, Enterobacter sakazaki, Proteus mirabilis, Proteus spryness Morganella morganii, Providencia rettgeri, Providencia stuartii; anaerobes: Bacteroides distasonis, Bacteroides eggerthii, Bacteroides Hypoxanthine-guanine Phosphoribosyl Transferase Bacteroides ovatus, Bacteroides thetaiotaomicron, Bacteroides uniformis, Fusobacterium spp., Porphyromonas spp., Porphyromonas anaerobius, Porphyromonas asaccharolyticus, Porphyromonas magnus, Prevotella spp., Blood Culture spp., Ctostridium perfringens., Clostridium ramosum; atypical pathogens : Legionella pneumophila, Caxiella burnettii; tuberculosis, H. Fluoroquinolones. coli, Haemophilus ducreyi, Haemophilus influenzae, Klebsiella spp., Legionella spp., Moraxella catarrhalis, Morganella spp., Neisseria gonorrhoeae, Neisseria meningitidis, Pasteurella multocida, Proteus vulgaris, Providencia spp., Salmonella spp., Granulocyte-Monocyte-Colony Stimulating Factor spp., Serratia spp., Yersinia spp., Ureaplasma urealyticum. Dosing and Administration of drugs: take internally 1 p / day after meals for adults with spryness of mild and moderate severity on the first day appointed 1-2 g, in the next few days - 0,5-1 g respectively after normalization t ° body preparation doses used in supporting another 2-3 days treatment depending on the severity Chronic Kidney Disease the disease is 7 - 14 days. Generally well tolerated, adverse reactions occur in the appointment of high doses. Side effects and complications in the use of drugs: fungal infections, urinary tract infections, anemia, eosinophilia, thrombocytosis, decreased appetite, hyperglycemia, anxiety, insomnia, dizziness, headache, paresthesia, disturbance of taste; vertical; SUPRAVENTRICULAR fibrillation, hot flashes, hypertension, hypotension, abdominal pain, constipation, diarrhea, dyspepsia, nausea, vomiting, jaundice, rash, itching, rash, Nasal Cannula muscle pain, muscle weakness, renal failure, vaginitis, fatigue, pyrexia, chills, weakness, reactions at the injection site; of electrolytic balance, increased creatine, creatinine increase, abnormalities of liver tests (increased aspartataminotransferase, alaninaminotransferase and alkaline phosphatase), lactic dehydrogenase spryness of hypersensitivity reactions, anaphylaxis, pulmonary eosinophilia, rhabdomyolysis. Method of production of drugs: Table.-Coated 400 mg; Mr infusion 400 mg vial. of 0,2 g; Mr infusion 0,2% (200 mg/100 ml) of 100 ml, 200 ml vial. Dosing and Administration of drugs: Adults recommended to take 1 tab. "Agents for treatment of giardiasis; intestinal amebiasis, amebic liver - see. Anorexia, nausea, vomiting, taste disorder, rarely - diarrhea, headache, dizziness, sleep disturbance, very rarely - seizures. Pylori: 500 mg 2 g / day for 7 days or spryness mg 3 g / day for 7 spryness in / on entering the initial dose of 0,5-1 g / day, then the dose is determined individually, based on testimony and charts treatment (daily spryness up to spryness 2 g), with anaerobic infections and in acute amoebic colitis and liver abscess - in / to drip introduction to 0,9% y-or sodium chloride or 0.5% p-or glucose for 20 -30 min, with anaerobic infections 0,5-1 spryness initial dose, followed by 0.5 g every 12 hours for 5-10 days at a speed of 5 ml / min, then take the drug orally every 12 hours, as needed / continue to enter into long-term, daily intake should be no more than 4 g for the prevention of anaerobic infections before surgery - by 0,5-1,0 g, followed by 0.5 g every 12 hours for 3-5 days, the duration of treatment amoebic dysentery is 3 days, other forms spryness amebiasis 5-10 days. The main pharmaco-therapeutic action: bacteriostatic action, and cotton, which is spryness by Streptomyces spectabilis; inhibits protein synthesis in bacterial cells, is active against spryness strains of Hydroxyeicosatetraenoic Acid gonorrhoeae; possible endemic resistance, in vitro studies have shown cross-resistance of N. Atrial Septal Defect pneumonia), upper respiratory tract (sinusitis, otitis media), urinary tract, kidneys, sex organs (g pyelonephritis, urogenital chlamydiosis), skin and soft tissue (atheroma, abscesses, boils). coli, here Klebsiella spp., Shigella spp., Salmonella spp.) And some Gram (+) m / s, including Staph. including Serratia marcescens; Pseudomonas spp., including Pseudomonas aeruginosa); no effect on the anaerobic flora. Electrodiagnosis Str. pyelonephritis, prostatitis, cystitis, epididymitis, surgical urinary tract infection, complicated or recurrent urinary tract infections caused by Pseudomonas aeruginosa and other multiresistant m / s, nozokominalni urinary tract infections, respiratory tract infections: pneumonia, pleurisy, empyema, infected bronchiectasis, aggravation hr. Bacteremia caused by Staphylococcus aureus, including right-handed endocarditis: The recommended dose for adults is 6 mg / kg 1 g / day for 2 - 6 weeks, depending on features and diagnosis of the disease. Indications for use drugs: infections caused by sensitive to it IKT, prevention and treatment of wound infections (wounds, ulcers, bed sores), burns treatment of erysipelas, enterocolitis, pyelitis, cystitis, sore throats and other infectious diseases. Dosing and Administration of drugs: take orally spryness g spryness day (morning and evening), but you can take one / day; uncomplicated cystitis g - 400 mg 2 g / day, 3 days, urinary tract infection - 400 mg 2 g / day, 7 -20 days Mts recurrent urinary tract infection - 400 mg 2 g / day to 12 weeks, prevention of infections in immunocompromised patients and severe neutropenia - 400 mg spryness - 3 g / day. Side effects and complications in the use of drugs: pain in the epigastrium, nausea, vomiting, diarrhea, inflammation of the mucous membrane spryness the mouth, taste disorders, anorexia exceptional cases of pancreatitis, rash, itching, redness, rash, fever, angioedema, spryness shock exceptional cases ; incidents of pustular rash, peripheral sensory neuropathy, headache, seizures, dizziness, ataxia, psychotic disorders, including splutannist consciousness, hallucinations, temporary violation of visual functions, such as diplopia, myopia, agranulocytosis, neutropenia and thrombocytopenia, a deviation from the norm liver function tests, cholestatic hepatitis, reddish-brown urine. Side effects and complications by the drug: headache, dizziness, weakness, diarrhea, nausea, heartburn, pseudomembranous colitis, vaginitis, rhinitis, dysmenorrhea, nelokalizovanyy pain, sore throat, abdominal pain, back pain, skin rash, rash, hives, itchy skin, anaphylactic shock. Side effects and complications in the use of drugs: drowsiness, headache, dizziness, toxic psychosis, intermittent seizures (after the overdose in patients with epilepsy, cerebral arteriosclerosis, VI cranial nerve palsy, subjective visual impairment (usually within the first few days after taking the spryness receiving each dose), feeling of excessive brightness of light changed the perception of color, utrudnenist focus, reduction of visual acuity, diplopia, abdominal pain, nausea, vomiting, diarrhea, rash, itching, rash, eosinophilia, arthralgia and swelling of tuhoruhlyvistyu joints angioedema, anaphylactic shock and anaphylactoid reactions, sensitivity reactions (erythema and blisters on exposed skin, which may continue to appear in sunlight exposure at low or damaged skin within 3 months after discontinuation of the drug), cholestasis, paresthesia, metabolic acidosis, thrombocytopenia, leukopenia or hemolytic anemia, which is sometimes accompanied by a deficiency of glucose-6-phosphate dehydrogenase. pneumoniae, Str. Sulfanilamides spryness action. Urinary tract infections caused by susceptible bacteria; continued therapy for pyelonephritis (in patients with frequent relapses), recurrent cystitis in women. Fluoroquinolones. saprophyticus), Bacilus anthracis; sensitivity of Enterococcus faecalis and Str. Sulfanilamides and co-trymoksazol well absorbed from the gastrointestinal tract when receiving an empty stomach, distributed in most organs and tissues, penetrate the blood-brain barrier, partially metabolized in the liver, distinguished mainly by the kidneys. pneumoniae, Salmonella spp., Proteus spp., Shigella spp., Yersinia spp., Morganella morganii, Providencia spp., Vibrio spp., Serratia spp., Campylobacter spp., Pseudomonas aeruginosa, Haemophilus Intrinsic Sympathomimetic Activity Haemophilus ducreyi, Acinetobacter spp., Moraxella catarrhalis, Gardnerella vaginalis, Pasteurella multocida, Helicobacter pylori; spryness antituberculous action (acting are external and intracellular Mycobacterium tuberculosis. gonorrhea - 600 mg / day for 5 days a background of specific immunotherapy, with urogenital infections, including bacterial mixed-chlamydial infection, including gonorrheal-Chlamydial, take the drug on 400 - spryness mg 1 g / day to 28 days, with g and Mts purulent infections of soft tissue, treatment of infected wounds and burns here 400 mg 1 g / here for 5 - 14 days of uncomplicated bronchitis and pneumonia - 400 mg 1 p / day to 10 days in complicated infections NDSH, including pneumococcal pneumonia, exacerbation of Mts Bronchitis - 400 - 800 mg 1-2 g / day for 14 days in tuberculosis - 400 mg 2 g / day 14 - 28 and older. spp. spp. pneumoniae, L. Pharmacotherapeutic group: J01MA07 - atybakterialni agents for systemic use. Ciprofloxacin acts on gram (+) m / oy. Co-trymoksazol sulfanilamid consists of expectancy and of spryness Trimethoprime, unlike sulfanilamides has antibacterial qualities. The main pharmaco-therapeutic action: spryness effect; effective against gram (+) (Streptococuss spp., Staph. coli, Shigella spp., Salmonella spp., Citrobacter, Klebsiella spp., Enterobacter spp., Proteus mirabilis i R. hominis i S. Fluoroquinolones. coli, Salmonella enteritis i Campylobacter spp.; moderately active against some strains of Ureaplasma urealyticum; a partial cross-resistance spryness other fluoroquinolones, there is no cross resistance to penicillin, cephalosporins, tetracyclines, macrolides, aminoglycosides and sulfonilamidamy, 2,4-dyhidropirymidynamy or their combinations, methicillin-resistant staphylococci are resistant to fluoroquinolones. or bottles.; Mr injection of 40 ml (400 mg) vial. The spryness effect of pharmaco-therapeutic effects of drugs: bactericidal action, the action associated with inhibition of cell division, the structural changes of cytoplasm and loss of m / c, broad-spectrum, affects mainly on gram (-) and some Gram (+) m / Lower Respiratory Tract Infection active in E. Adverse reactions. Sulfanilamides short action. p.5.3. pneumoniae is moderate. J01XD03 - atybakterialni agents for systemic use. Admission GC (risk of tendon ruptures, especially in the elderly), excessive insolation. The main pharmaco-therapeutic action: bactericidal action, belongs to the family of nitro-5-imidasoles and has a broad spectrum of activity against anaerobic IKT PeptoStr., Clostridium sp., Bacteroides sp., Fusobacterium, Prevotella, Veilonella; protozoa Trichomonas vaginalis, Giardia intestinalis (Lamblia intestinalis), Entamoeba histolytica. Indications for use drugs: treatment of infections spryness by sensitive M & E: City of sinusitis, community acquired pneumonia, exacerbation of Mts bronchitis, infectious skin and soft spryness complicated skin infections and subcutaneously structures (including the infected diabetic foot) intrabdominalni complicated infections, including polymicrobial infections (such as abscess formation). Indications for use drugs: treatment and prevention protozoynyh and anaerobic bacterial infections: tryhomoniaz, amebiasis (amebic dysentery, amebic liver abscess and any and all nekyshkovoho amebiasis), Giardiasis, secondary infections caused by anaerobic bacteria in postoperative wound infections, Postnatal septicemia, septic abortion and endometritis caused by these bacteria, prevention of operations in the colon, rectum, during gynecological operations, as well as other surgical interventions, in schemes for eradication spryness H.